user

BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN CENTRAL AMERICA

被引：0
|
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mogollon, Mayorga W. [2 ]
Chavez, M. A. [3 ]
Patino, A. [1 ]
Herran, S. E. [1 ]
Marrugo, R. [1 ]
机构：
[1] Bayer, Bogota, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, San Jose, Costa Rica
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE311
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [21] Inside CKD: modelling the direct economic burden of concomitant chronic kidney disease and type 2 diabetes
    Power, A.
    Arnlov, J.
    Batista, M. C.
    Card-Gowers, J.
    Chadban, S.
    Chertow, G. M.
    De Nicola, L.
    Halimi, J. -M.
    Kanda, E.
    Li, G.
    Mennini, F. S.
    Navarro-Gonzalez, J. F.
    Sanchez, J. J. G.
    Tangri, N.
    Wish, J.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 322 - 323
  • [22] Chronic kidney disease (CKD) in US adults with type 2 diabetes (T2D) and/or cardiovascular diseases (CVD): A national estimate of prevalence by KDIGO 2012 classification
    Wang, Tongtong
    Xi, Yuzhi
    Lubwama, Robert
    Koro, Carol
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 84 - 84
  • [23] sRAGE-A Biomarker of Kidney Disease in Youth-Onset Type 2 Diabetes (T2D)
    Bacha, Fida
    Urbina, Elaine M.
    Gidding, Samuel
    Monnier, Vincent M.
    El Ghormli, Laure
    Drews, Kimberly
    Braffett, Barbara H.
    [J]. DIABETES, 2023, 72
  • [24] ECONOMIC BURDEN OF MODERATE CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES
    McQueen, R. B.
    Farahbakhshian, S.
    Bell, K.
    Nair, K.
    Saseen, J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A14 - A14
  • [25] ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES IN TURKIYE
    Kurnaz, M.
    Yildiz, A.
    Oguz, A.
    Turkmen, E.
    Karatas, A.
    Buyukisik, T.
    Ozturk, F.
    Okcun, S.
    Erkut, Y.
    Kockaya, G.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S163 - S163
  • [26] Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Cherney, David
    Charbonnel, Bernard
    Mcguire, Darren K.
    Cosentino, Francesco
    Shih, Weichung J.
    Liu, Jie
    Frederich, Robert
    Mancuso, James P.
    Raji, Annaswamy
    Gantz, Ira
    [J]. DIABETES, 2021, 70
  • [27] Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)
    Sirovich, Lawrence
    [J]. PLOS ONE, 2014, 9 (01):
  • [28] Primary Care Detection of Chronic Kidney Disease in Adults with Type-2 Diabetes: The ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease)
    Szczech, Lynda A.
    Stewart, Rebecca C.
    Su, Hsu-Lin
    DeLoskey, Richard J.
    Astor, Brad C.
    Fox, Chester H.
    McCullough, Peter A.
    Vassalotti, Joseph A.
    [J]. PLOS ONE, 2014, 9 (11):
  • [29] Change in Albuminuria Measured by Urine Albumin-toCreatinine Ratio (UACR) and Associated Clinical Outcomes in Patients With Chronic Kidney Disease (CKD) Associated With Type 2 Diabetes (T2D)
    Tangri, Navdeep
    Li, Qixin
    Chen, Yan
    Singh, Rakesh
    Betts, Keith A.
    Farag, Youssef M.
    Beeman, Scott
    Du, Yuxian
    Kong, Sheldon X.
    Williamson, Todd
    Wu, Aozhou
    Sundar, Manasvi
    Pantalone, Kevin M.
    [J]. CIRCULATION, 2023, 148
  • [30] ECONOMIC & HUMANISTIC BURDEN OF TYPE 2 DIABETES WITH CHRONIC KIDNEY DISEASE IN BRAZIL
    Marx, Steven
    Pomerantz, Dave
    Vietri, Jeffrey
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 133 - 133
12345